Anti-IL-13 in Inflammatory Bowel Disease: From the Bench to the Bedside

E-ISSN： 1873-5592|14|12|1444-1452

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.12, 2013-11, pp. : 1444-1452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-IL-12/23 in Crohn's Disease: Bench and Bedside

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1379-1384

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Angiogenesis by Non-Steroidal Anti-Inflammatory Drugs: From the Bench to the Bedside and Back

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-01 ,pp. : 31-38

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach

Current Drug Targets, Vol. 12, Iss. 11, 2011-10 ,pp. : 1595-1653

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1508-1521

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular NO: from bench to bedside

By Tsikas Dimitrios

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 3-3

Springer Publishing Company

Access to resources Recommend Favorite